893P Clinico-genetic profiling of HRAS mutant head and neck squamous cell carcinoma (HNSCC)
Year: 2021
Type: article
Source: Annals of Oncology
Authors: X. Le, K. Marcelo, N. Coleman, J. Hopkins, B. Balsara, M. Leoni, A.R. Spelman, D.S. Hong, L.A. Albacker, M. Gillison
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Roche, Gilead Sciences, American Society of Clinical Oncology, Celgene, Johns Hopkins University, Society for Immunotherapy of Cancer, Ipsen Biopharmaceuticals, Clovis Oncology, Mirati Therapeutics, Bayer HealthCare, Daiichi-Sankyo, Eisai, Ipsen, Bavarian Nordic, Genentech, EMD Serono, Ignyta, Foundation Medicine, National Cancer Institute
OpenAlex ID: W3202065865